200 related articles for article (PubMed ID: 28512247)
41. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
42. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma.
Jung N; Kwon HJ; Jung HJ
Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404
[TBL] [Abstract][Full Text] [Related]
44. Survivin Inhibition by Piperine Sensitizes Glioblastoma Cancer Stem Cells and Leads to Better Drug Response.
Warrier NM; Krishnan RK; Prabhu V; Hariharapura RC; Agarwal P; Kumar P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886952
[TBL] [Abstract][Full Text] [Related]
45. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
46. ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells.
Jimenez-Pascual A; Hale JS; Kordowski A; Pugh J; Silver DJ; Bayik D; Roversi G; Alban TJ; Rao S; Chen R; McIntyre TM; Colombo G; Taraboletti G; Holmberg KO; Forsberg-Nilsson K; Lathia JD; Siebzehnrubl FA
Cancer Discov; 2019 Nov; 9(11):1574-1589. PubMed ID: 31434712
[TBL] [Abstract][Full Text] [Related]
47. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications.
Yang L; Lin C; Wang L; Guo H; Wang X
Exp Cell Res; 2012 Nov; 318(19):2417-26. PubMed ID: 22906859
[TBL] [Abstract][Full Text] [Related]
49. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.
Tilghman J; Schiapparelli P; Lal B; Ying M; Quinones-Hinojosa A; Xia S; Laterra J
Neoplasia; 2016 Mar; 18(3):185-98. PubMed ID: 26992919
[TBL] [Abstract][Full Text] [Related]
50. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
[TBL] [Abstract][Full Text] [Related]
51. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
52. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.
Chigurupati S; Venkataraman R; Barrera D; Naganathan A; Madan M; Paul L; Pattisapu JV; Kyriazis GA; Sugaya K; Bushnev S; Lathia JD; Rich JN; Chan SL
Cancer Res; 2010 Jan; 70(1):418-27. PubMed ID: 20028870
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
Ji T; Zhang X; Li W
Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
[TBL] [Abstract][Full Text] [Related]
54. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.
Yang W; Liu Y; Gao R; Yu H; Sun T
Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038
[TBL] [Abstract][Full Text] [Related]
55. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
[TBL] [Abstract][Full Text] [Related]
56. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
[TBL] [Abstract][Full Text] [Related]
58. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
Rath BH; Wahba A; Camphausen K; Tofilon PJ
Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
[TBL] [Abstract][Full Text] [Related]
59. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
Rahme GJ; Luikart BW; Cheng C; Israel MA
Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
[TBL] [Abstract][Full Text] [Related]
60. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
